Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Long Cao

Showing results (501-510 of 517) with videos related to

Pageof 52
Sort By:
The New Phytologist|January 12, 2019
Osa-miR398b boosts H<sub>2</sub> O<sub>2</sub> production and rice blast disease-resistance via multiple superoxide dismutasesYan Li, Xiao-Long Cao, Yong Zhu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 13, 2022
Postoperative follow-up for gastric cancer needs to be individualized according to age, tumour recurrence pattern, and recurrence timeWen-Wu Qiu, Qi-Yue Chen, Wen-Ze Zheng, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 7, 2021
Body composition parameters predict pathological response and outcomes in locally advanced gastric cancer after neoadjuvant treatment: A multicenter, international studyJian-Xian Lin, Yi-Hui Tang, Wen-Xing Zhou, et al.
The Oncologist|November 25, 2018
Prognosis of Young Survivors of Gastric Cancer in China and the U.S.: Determining Long-Term Outcomes Based on Conditional SurvivalQi-Yue Chen, Qing Zhong, Wei Wang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 29, 2026
Integrating multi-omics data for enhanced prognosis prediction in gastric cancer post-neoadjuvant therapyZe-Ning Huang, Hao-Xiang Zhang, Feng Chen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 5, 2023
A scoring model for predicting early recurrence of gastric cancer with normal preoperative tumor markers: A multicenter studyChang-Yue Zheng, Ju Wu, Chun-Sen Chen, et al.
The Oncologist|September 1, 2020
Modified ypTNM Staging Classification for Gastric Cancer after Neoadjuvant Therapy: A Multi-Institutional StudyQing Zhong, Qi-Yue Chen, Amilcare Parisi, et al.
Nature Communications|April 20, 2022
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese populationYuanyuan Qu, Jinwen Feng, Xiaohui Wu, et al.
Nature Communications|November 17, 2023
Indocyanine green fluorescence imaging-guided versus conventional laparoscopic lymphadenectomy for gastric cancer: long-term outcomes of a phase 3 randomised clinical trialQi-Yue Chen, Qing Zhong, Zhi-Yu Liu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 31, 2025
Identifying chemotherapy benefits in high-risk patients with stage IB gastric cancer based on recurrence prediction value: A multicenter retrospective studyQi-Chen He, Ze-Ning Huang, Yu-Bin Ma, et al.
Pageof 52

Showing results (501-510 of 517) with videos related to

Sort By:
Pageof 52
The New Phytologist|January 12, 2019
Osa-miR398b boosts H<sub>2</sub> O<sub>2</sub> production and rice blast disease-resistance via multiple superoxide dismutasesYan Li, Xiao-Long Cao, Yong Zhu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 13, 2022
Postoperative follow-up for gastric cancer needs to be individualized according to age, tumour recurrence pattern, and recurrence timeWen-Wu Qiu, Qi-Yue Chen, Wen-Ze Zheng, et al.
Clinical Nutrition (Edinburgh, Scotland)|August 7, 2021
Body composition parameters predict pathological response and outcomes in locally advanced gastric cancer after neoadjuvant treatment: A multicenter, international studyJian-Xian Lin, Yi-Hui Tang, Wen-Xing Zhou, et al.
The Oncologist|November 25, 2018
Prognosis of Young Survivors of Gastric Cancer in China and the U.S.: Determining Long-Term Outcomes Based on Conditional SurvivalQi-Yue Chen, Qing Zhong, Wei Wang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 29, 2026
Integrating multi-omics data for enhanced prognosis prediction in gastric cancer post-neoadjuvant therapyZe-Ning Huang, Hao-Xiang Zhang, Feng Chen, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 5, 2023
A scoring model for predicting early recurrence of gastric cancer with normal preoperative tumor markers: A multicenter studyChang-Yue Zheng, Ju Wu, Chun-Sen Chen, et al.
The Oncologist|September 1, 2020
Modified ypTNM Staging Classification for Gastric Cancer after Neoadjuvant Therapy: A Multi-Institutional StudyQing Zhong, Qi-Yue Chen, Amilcare Parisi, et al.
Nature Communications|April 20, 2022
A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese populationYuanyuan Qu, Jinwen Feng, Xiaohui Wu, et al.
Nature Communications|November 17, 2023
Indocyanine green fluorescence imaging-guided versus conventional laparoscopic lymphadenectomy for gastric cancer: long-term outcomes of a phase 3 randomised clinical trialQi-Yue Chen, Qing Zhong, Zhi-Yu Liu, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 31, 2025
Identifying chemotherapy benefits in high-risk patients with stage IB gastric cancer based on recurrence prediction value: A multicenter retrospective studyQi-Chen He, Ze-Ning Huang, Yu-Bin Ma, et al.
Pageof 52